Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amnesia | x | x | x | x | x | x | x | x | |||||||
| Apprehension | x | x | |||||||||||||
| Convulsion | x | ||||||||||||||
| Convulsive seizure | x | ||||||||||||||
| Distress | x | ||||||||||||||
| Drowsiness | x | x | |||||||||||||
| Epilepsy | x | ||||||||||||||
| Insomnia | x | ||||||||||||||
| Laceration | x | x | x | x | |||||||||||
| Memory impairment | x | x | |||||||||||||
| Short period | x | x | x | x | |||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |